Cargando…
Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
Recent clinical trials have shown several multi-target tyrosine kinase inhibitors (TKIs) to be effective in the treatment of osteosarcoma. However, these TKIs have a number of targets, and it is yet unclear which of these targets has a key role in osteosarcoma treatment. In this review, we first sum...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485562/ https://www.ncbi.nlm.nih.gov/pubmed/32984034 http://dx.doi.org/10.3389/fonc.2020.01642 |